New tests could help spot hidden blood disorder in seniors

NCT ID NCT01648556

Completed Knowledge-focused Sponsor: Centre Hospitalier Universitaire, Amiens Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study followed 37 adults over age 60 with unexplained low platelet counts to see if certain tests could predict immune thrombocytopenic purpura (ITP). Participants had blood tests, bone marrow biopsies, and a short course of the steroid prednisone. The goal was to find which tests best point to ITP, helping doctors avoid unnecessary procedures and start the right treatment sooner.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: prednisone
What this could lead to: If successful, this could help doctors better diagnose immune thrombocytopenia in older adults, leading to more targeted treatment.
What could go wrong: This is a small, completed study with only 37 participants. The results may not apply to all patients, and the tests studied might not be reliable enough for routine use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMMUNE THROMBOCYTOPENIC PURPURA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autoimmune thrombocytopenic purpura thrombocytopenic purpura

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PURPURA THROMBOPENIC

Contacts and locations

Locations

CHU Amiens

Amiens, 80000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.